Ascend Wellness Holdings (AAWH) Asset Writedowns and Impairment (2021 - 2026)

Ascend Wellness Holdings' (AAWH) quarterly Asset Writedowns and Impairment came in at $744000.0 in Q1 2026, down 61.27% year-on-year from $1.9 million in Q1 2025, and down 71.16% quarter-over-quarter from $2.6 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Asset Writedowns and Impairment (2021 - 2026) Analysis & Trends

Ascend Wellness Holdings' Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at $744000.0 for Q1 2026.

  • On a quarterly basis, Asset Writedowns and Impairment fell 61.27% year-over-year to $744000.0 in Q1 2026; TTM through Mar 2026 was $15.7 million, a 57.1% increase from a year earlier, with the FY2025 full-year figure at $16.9 million, up 37.86% from the prior year.
  • Asset Writedowns and Impairment slipped to $744000.0 in Q1 2026 per AAWH's latest filing, from $2.6 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $8.4 million in Q2 2023 and bottomed at $112000.0 in Q2 2022.
  • The 5-year median for Asset Writedowns and Impairment is $4.2 million (2024), against an average of $4.0 million.
  • Across the five-year window, Asset Writedowns and Impairment jumped 7442.86% in 2023 and slumped 86.96% in 2024, its largest moves.
  • Year by year, Asset Writedowns and Impairment stood at $8.0 million in 2022, then sank by 53.86% to $3.7 million in 2023, then slumped by 86.96% to $484000.0 in 2024, then surged by 433.06% to $2.6 million in 2025, then sank by 71.16% to $744000.0 in 2026.
  • Per Business Quant, the three latest AAWH Asset Writedowns and Impairment figures stand at $744000.0 (Q1 2026), $2.6 million (Q4 2025), and $7.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Ascend Wellness Holdings 78.95 Mn 18.03 Mn 44.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 744,000.00
Mar 31, 2026 744,000.00
Dec 31, 2025 2.58 Mn
Dec 31, 2025 2.58 Mn
Sep 30, 2025 7.10 Mn
Sep 30, 2025 7.10 Mn
Jun 30, 2025 5.28 Mn
Jun 30, 2025 5.28 Mn
Mar 31, 2025 1.92 Mn
Mar 31, 2025 1.92 Mn
Dec 31, 2024 484,000.00
Dec 31, 2024 484,000.00
Sep 30, 2024 4.46 Mn
Sep 30, 2024 4.46 Mn
Jun 30, 2024 3.14 Mn
Jun 30, 2024 3.14 Mn
Mar 31, 2024 4.17 Mn
Mar 31, 2024 4.17 Mn
Dec 31, 2023 3.71 Mn
Dec 31, 2023 3.71 Mn